Our products are designed to address the essential areas of dermatology.
We launched Cassiopea with a deliberate goal in mind: find a new way to treat acne. We are building our company on this foundation, targeting unmet needs and opportunities for Cassiopea to advance the practice of dermatology.
Acne, a chronic inflammatory skin disease, is one of the most common reasons patients visit a dermatologist. The major product classes predominantly used to treat acne have been available for nearly 40 years, and we believe that recent growth in this market has been significantly limited by a lack of innovation in new product development.
AGA is the most common cause of hair loss,4 affecting a large percentage of both men and women. The prescription treatment options are limited, yet there is a growing demand for choices as many patients choose OTC remedies.
AGA is another major contributor to confidence loss that deserves a new treatment. Many patients remain untreated and continue to suffer in silence.
Genital warts are a symptom of the highly contagious sexually transmitted disease, human papillomavirus (HPV). They are spread through direct skin-to-skin contact, often by those who do not develop genital warts and therefore do not know they are infected. Today, topical treatments are common, but many require multiple applications and can be ineffective—recurrence is frequent.
Genital warts can adversely affect sexual health and wellness. Finding effective treatment is imperative.
References: 1. American Academy of Dermatology (AAD). Skin conditions by the numbers. AAD website. https://www.aad.org/media/stats/conditions/skin-conditions-by-the-numbers. Accessed July 24, 2019. 2. Global Market Insights (GMI). Acne medication market size by formulation (topical, oral), by product (retinoids, antibiotics, salicylic acid, benzoyl peroxide, azelaic acid), by type (prescription, OTC), by age group (0-10 years, 11-16 years, 17-25 years, 26-40 years, 41-60 years, 61-80 years, 80+ years), industry analysis report, regional outlook (U.S., Canada, Germany, UK, Italy, France, Spain, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia), application potential, competitive market share & forecast, 2018-2024. GMI website. Accessed July 25, 2019. 3. Layton A. The use of isotretinoin in acne. Dermatoendocrinol. 2009;1(3):162-169. 4. Qi J, Garza LA. An overview of alopecias. Cold Spring Harb Perspect Med. 2014;4(3):1. 5. Ho CH, Zito PM. Androgenetic alopecia. Treasure Island, FL; StatPearls Publishing; 2019. 6. Centers for Disease Control and Prevention (CDC). Genital HPV infection – fact sheet. CDC website. https://www.cdc.gov/std/hpv/stdfact-hpv.htm. Accessed July 23, 2019. 7. Anal Cancer Foundation (ACF). About HPV/treatment/warts. ACF website. https://www.analcancerfoundation.org/about-hpv/treatment/warts/. Accessed July 24, 2019. 8. American Sexual Health Association (ASHA). Fast facts. ASHA website. http://www.ashasexualhealth.org/stdsstis/hpv/fast-facts/. Accessed July 23, 2019.
Cassiopea SpA announces approval of delisting of its shares on SIX Swiss Exchange
Cassiopea announces filing for delisting of its registered shares from SIX Swiss Exchange
Cassiopea SpA announces preparing delisting of shares on SIX Swiss Exchange
Breezula is under investigation in the United States for the treatment of androgenetic alopecia, and the safety and efficacy have not been established by the United States Food and Drug Administration (FDA). The proposed brand name for clascoterone solution 7.5% is not FDA-approved.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc placerat consequat massa. Integer et imperdiet dolor. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nullam in sapien in eros imperdiet iaculis vel quis leo. Nullam risus tortor, ornare ut risus non, bibendum pretium nulla. Sed eu sollicitudin orci. Nam pretium lectus non purus cursus scelerisque. Nunc felis arcu, lacinia dignissim condimentum sed, ultrices a turpis. In nibh urna, auctor vel ornare id, ornare sed orci. Donec ultrices elit quis ipsum sagittis tristique. Etiam finibus tortor id felis varius, eu accumsan nisl rutrum. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer sed nisl mollis, lacinia lectus nec, porta lectus. In placerat orci diam, ornare sodales enim ornare sed. Pellentesque aliquet, leo quis pulvinar porta, sapien ex cursus leo, ut porta eros justo vitae elit. Morbi consequat ac augue et rhoncus. Phasellus aliquet arcu nisi, sed lacinia mi tristique ac. Quisque ultrices, arcu vitae pulvinar pellentesque, mi orci ultrices felis, a pulvinar diam nulla id mauris. Duis a ante sem. Sed ac ex non tortor ornare viverra nec in magna. Lorem ipsum dolor sit amet, consectetur adipiscing elit. In dictum tellus eget sagittis interdum. In ante sem, pellentesque a ultrices non, ultrices id odio. Curabitur at lacinia elit, ut placerat lectus. Morbi sollicitudin sapien vitae rhoncus dapibus.
